Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to reveal his favorite stocks in the market.

Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as ...

Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

TEANECK, N.J. - Cognizant Technology Solutions Corporation (NASDAQ:CTSH), a prominent player in the IT Services industry with ...

Cognizant (CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (GILD) that aims to ...

Thursday announced that it has expanded its long-standing collaboration with Gilead Sciences (GILD) to enhance cost ...

The testimony of Srimanikandan Ramamoorthy, dubbed the essential witness by the US Department of Justice, is critical, ...

A US court has requested Cognizant to specify the nature of its trade secrets after Infosys denied the theft allegations, ...

Get the latest updates on the company's financial performance, strategic acquisitions, and market shifts. Explore detailed ...

Cognizant sued Infosys, accusing it of stealing secrets related to its US subsidiary TriZetto's healthcare insurance software ...

Cognizant will continue to support key enterprise areas such as global finance systems and human capital management.

A new AI development framework and services are said to fast track multi-agent adoption by enabling interoperability and scalability to transform business processes.